ESSA Pharma Inc (EPIX) Stock Price & Overview
NASDAQ:EPIX • CA29668H7085
Current stock price
The current stock price of EPIX is 0.2012 USD. Today EPIX is down by -1.85%. In the past month the price decreased by -1.85%. In the past year, price decreased by -96.77%.
EPIX Key Statistics
- Market Cap
- 9.519M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.64
- Dividend Yield
- N/A
EPIX Stock Performance
EPIX Stock Chart
EPIX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to EPIX. When comparing the yearly performance of all stocks, EPIX is a bad performer in the overall market: 99.79% of all stocks are doing better.
EPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to EPIX. EPIX has a great financial health rating, but its profitability evaluates not so good.
EPIX Earnings
EPIX Forecast & Estimates
7 analysts have analysed EPIX and the average price target is 1.73 USD. This implies a price increase of 761.83% is expected in the next year compared to the current price of 0.2012.
EPIX Groups
Sector & Classification
EPIX Financial Highlights
Over the last trailing twelve months EPIX reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS decreased by -6.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.73% | ||
| ROE | -23.07% | ||
| Debt/Equity | 0 |
EPIX Ownership
EPIX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.11 | 380.121B | ||
| AMGN | AMGEN INC | 15.21 | 190.443B | ||
| GILD | GILEAD SCIENCES INC | 15.76 | 174.171B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.65 | 113.617B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.19 | 82.171B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.97 | 43.596B | ||
| INSM | INSMED INC | N/A | 35.536B | ||
| NTRA | NATERA INC | N/A | 28.801B | ||
| BIIB | BIOGEN INC | 11.03 | 26.972B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.62 | 24.995B | ||
| MRNA | MODERNA INC | N/A | 19.759B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.548B | ||
| INCY | INCYTE CORP | 12.34 | 18.767B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About EPIX
Company Profile
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
Company Info
IPO: 2021-02-22
ESSA Pharma Inc
999 West Broadway, Suite 720
Vancouver BRITISH COLUMBIA V5Z 1K5 CA
CEO: David Parkinson
Employees: 35
Phone: 17783310962
ESSA Pharma Inc / EPIX FAQ
What does ESSA Pharma Inc do?
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
What is the current price of EPIX stock?
The current stock price of EPIX is 0.2012 USD. The price decreased by -1.85% in the last trading session.
What is the dividend status of ESSA Pharma Inc?
EPIX does not pay a dividend.
What is the ChartMill technical and fundamental rating of EPIX stock?
EPIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the upcoming dividend date for ESSA Pharma Inc?
The next ex-dividend date for ESSA Pharma Inc (EPIX) is August 25, 2025.
Would investing in ESSA Pharma Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EPIX.